Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$50.89 USD
-3.07 (-5.69%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $50.35 -0.54 (-1.06%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
Hims & Hers Health, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical Info Systems industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
HIMS 50.89 -3.07(-5.69%)
Will HIMS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HIMS
Hims & Hers Expands AI and Technology Focus to Advance Digital Care
Company News for Sep 16, 2025
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Hims & Hers Health, Inc. (HIMS) Stock Sinks As Market Gains: Here's Why
OMCL or HIMS: Which Is the Better Value Stock Right Now?
Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know
Other News for HIMS
Hims & Hers Stock (HIMS) Slumps as FDA Slams Its ‘False’ Weight Loss Drug Products
Trump announces $15B libel suit against New York Times: Morning Buzz
Trump announces $15B libel suit against New York Times: Morning Buzz
HIMS Stock Dips After FDA Warning on Marketing Claims
Trump announces $15 libel suit against New York Times: Morning Buzz